Altre lingue Aquestive Therapeutics, Inc.

Azioni

AQST

US03843E1047

Tempo reale stimato Cboe BZX Altri mercati azionari 17:52:30 01/05/2024			Variaz. 5gg	Var. 1 gen.
3,26 ^USD	-2,98%		-15,64%	+62,87%

29/04	Aquestive Therapeutics ottiene l'approvazione della FDA per Libervant nel trattamento delle crisi epilettiche nei bambini	MT
29/04	Transcript : Aquestive Therapeutics, Inc. - Special Call

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children	29/04
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film	29/04
Aquestive Therapeutics, Inc Receives U.S. FDA Approval and Market Access for Libervant? Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm? (epinephrine) Sublingual Film	29/04
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET	25/04
Aquestive Therapeutics to Present Crossover Study Data for Libervant Buccal Film at 76th Annual Meeting of the American Academy of Neurology	15/04
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology	12/04
Aquestive Therapeutics, Inc. to Present Crossover Study Data for Libervant Buccal Film At 76th Annual Meeting of the American Academy of Neurology	12/04
Aquestive Therapeutics Files $250 Million Mixed Shelf	03/04
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01/04
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01/04
Aquestive Therapeutics, Inc. Appoints Abigail Jenkins to Board of Directors, Effective April 1, 2024	01/04
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock	25/03
Top Midday Decliners	20/03
Sector Update: Health Care Stocks Steady Premarket Wednesday	20/03
Wall Street Set to Open Flat as Investors Look Toward Fed Decision; Oil Prices Drop Sharply	20/03
Top Premarket Decliners	20/03
Aquestive Therapeutics Prices $75 Million Common Stock Offering; Shares Slump Premarket	20/03
Aquestive Therapeutics Prices $75 Million Common Stock Offering	20/03
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock	20/03
Aquestive Therapeutics Proposes Public Stock Offering -- Shares Drop	19/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aquestive Therapeutics, Inc.

Azioni

AQST

US03843E1047

Altre lingue

Filtri